---
layout: post.njk
title: Test 5
date: 2025-04-21T15:37:00.000Z
tags: post
featuredImage: /assets/images/uploads/screenshot-2025-04-22-09.53.56.png
excerpt: Lorem ipsum dolor sit amet consectetur adipiscing elit eros, quis
  nostra fringilla imperdiet sodales semper auctor senectus metus, penatibus eu
  ullamcorper duis pretium etiam vestibulum. Condimentum iaculis elementum porta
  nostra taciti eget convallis, ac nec sociosqu aliquet libero. Sem augue litora
  aenean nulla dictum dictumst ad eget scelerisque felis, erat ac id nunc
  cubilia pretium nullam mattis netus interdum primis, molestie porta odio
  fringilla porttitor pharetra tortor sociosqu velit.
featured: true
featured_center: false
---
Lorem ipsum dolor sit amet consectetur adipiscing elit eros, quis nostra fringilla imperdiet sodales semper auctor senectus metus, penatibus eu ullamcorper duis pretium etiam vestibulum. Condimentum iaculis elementum porta nostra taciti eget convallis, ac nec sociosqu aliquet libero. Sem augue litora aenean nulla dictum dictumst ad eget scelerisque felis, erat ac id nunc cubilia pretium nullam mattis netus interdum primis, molestie porta odio fringilla porttitor pharetra tortor sociosqu velit.

<!-- Chart Container -->
<div class="visualization-container breakout-medium story-emphasis" id="biotech-ipo-outcomes">
    <div class="chart-header">
        <h3>What Really Happens to Biotech IPOs</h3>
        <p class="chart-subtitle">Most remain independent, challenging acquisition assumptions</p>
    </div>
    <div id="biotech-donut-chart"></div>
    <div class="chart-footer">
        <p class="chart-caption">Analysis of 168 biotech companies that completed IPOs. "Distressed" includes reverse mergers, liquidations, bankruptcies, and OTC trading.</p>
        <p class="data-source">Source: Company research and analysis</p>
    </div>
</div>

<!-- Screen Reader Accessible Table -->
<table class="sr-only" summary="Biotech IPO outcomes showing that 73% remain independent">
    <caption>What Really Happens to Biotech IPOs: Most remain independent, challenging acquisition assumptions</caption>
    <thead>
        <tr>
            <th scope="col">Category</th>
            <th scope="col">Number of Companies</th>
            <th scope="col">Percentage</th>
            <th scope="col">Description</th>
        </tr>
    </thead>
    <tbody>
        <tr>
            <th scope="row">Still Independent</th>
            <td>122</td>
            <td>72.6%</td>
            <td>Companies that remain listed and independent</td>
        </tr>
        <tr>
            <th scope="row">Acquired</th>
            <td>23</td>
            <td>13.7%</td>
            <td>Companies acquired by other firms</td>
        </tr>
        <tr>
            <th scope="row">Distressed</th>
            <td>23</td>
            <td>13.7%</td>
            <td>Companies experiencing distress: reverse mergers, liquidations, bankruptcies, or OTC trading</td>
        </tr>
    </tbody>
</table>

<!-- D3.js and Chart Initialization -->
<script src="https://cdnjs.cloudflare.com/ajax/libs/d3/7.8.5/d3.min.js"></script>
<script type="module">
    import { BiotechIPODonutChart } from '/assets/js/charts/custom/biotech-ipo-outcomes-donut.js';
    
    // Story configuration (optional customization)
    const storyConfig = {
        primaryStory: "73% of biotech IPOs remain independent",
        keyInsights: [
            "3 in 4 biotech companies remain independent after going public",
            "Only 1 in 7 companies are acquired",
            "Distress rate equals acquisition rate at 13.7%"
        ],
        emphasisElements: ["Still Independent segment dominance"]
    };
    
    // Initialize chart
    document.addEventListener('DOMContentLoaded', async function() {
        const chart = new BiotechIPODonutChart('#biotech-donut-chart', storyConfig);
        await chart.render('/_data/processed/biotech-ipo-outcomes.json');
        
        // Run quality tests (optional - for development)
        setTimeout(() => {
            runPublicationQualityTests('#biotech-donut-chart');
        }, 500);
    });
    
    // Responsive handling
    window.addEventListener('resize', debounce(() => {
        const chart = new BiotechIPODonutChart('#biotech-donut-chart', storyConfig);
        chart.render('/_data/processed/biotech-ipo-outcomes.json');
    }, 250));
    
    function debounce(func, wait) {
        let timeout;
        return function executedFunction(...args) {
            const later = () => {
                clearTimeout(timeout);
                func(...args);
            };
            clearTimeout(timeout);
            timeout = setTimeout(later, wait);
        };
    }
    
    // Quality assurance function
    function runPublicationQualityTests(containerId) {
        console.group('üìä Publication Quality Tests');
        
        const container = document.querySelector(containerId);
        console.assert(container, `‚ùå Container ${containerId} not found`);
        console.assert(container.children.length > 0, `‚ùå Container ${containerId} is empty`);
        
        const svg = container.querySelector('svg');
        if (svg) {
            console.assert(svg.getAttribute('role') === 'img', '‚ùå SVG missing accessibility role');
            console.assert(svg.getAttribute('aria-label'), '‚ùå SVG missing aria-label');
            
            const segments = svg.querySelectorAll('.arc-segment');
            console.assert(segments.length === 3, '‚ùå Expected 3 chart segments');
        }
        
        console.log('‚úÖ All publication quality tests passed');
        console.groupEnd();
    }
</script>

Ad accumsan praesent natoque pellentesque rhoncus varius lectus semper, nisl sed malesuada tempus eu iaculis lacus et penatibus, vehicula rutrum convallis taciti congue luctus netus. Primis dictum malesuada lobortis neque enim habitasse eu nisl lectus, pellentesque litora scelerisque ad vitae ac sociis fames, habitant potenti morbi ut pulvinar curabitur rhoncus blandit. Platea fames congue urna semper non netus felis suspendisse, justo euismod pulvinar curae accumsan aliquet cras suscipit, ridiculus mi purus sem nostra class egestas.
